PATENT CLAIM ANALYSIS

Application Number: 15961002
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-03
Patent Classification: ["514", "230500"]

Abstract:
Methods of treating developmental disorders and/or seizure disorders with etifoxine, a deuterated analog of etifoxine, or a pharmaceutically acceptable salt, solvate, or prodrug thereof are provided. The methods provide therapeutic compositions that may be used to improve one or more symptoms of the developmental disorder and/or seizure disorder.

Claim (Index 1):
A method of treating autism comprising administering to a patient in need thereof, a therapeutically effective dosage of etifoxine or a pharmaceutically acceptable salt thereof, wherein the method provides improvement in one or more symptoms of autism in the patient and the improvement is provided for at least 12 hours after administration.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 91.0
- Lexical Diversity: 1.38462
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15680417', '15191068', '14876110', '15493374', '15904901']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7651128081519316
- 35 USC 102 Novelty (BERT): 0.5305222867224056
- Combined Prediction Score: 0.7416537560089791
- Mean Citation Score: 289.026612
- Max Citation Score: 344.95847000000015
- Similarity Product: 210.8660779105365

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test